Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that the United States Patent and ...

The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. ANIXA BIOSCIENCES INC (ANIX) is a stock that can certainly grab ...

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In the 'long' context, investors will be essentially be "buying high, but hoping to sell even ...

The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Has ANIXA BIOSCIENCES INC (ANIX) been one of those stocks this ...

Maxim Group assumed coverage on shares of Anixa Biosciences (NASDAQ:ANIX – Free Report) in a research note released on Friday, Marketbeat reports. The firm issued a buy rating and a $10.00 price ...

Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that the Chinese National Intellectual ...

ANIX has a dual-platform approach. It has an FSHR‑targeted CAR‑T program for ovarian cancer and an α‑lactalbumin breast cancer vaccine. Their Phase 1 CAR‑T showed reasonable safety, as one patient ...

On Tuesday, Anixa Biosciences, Inc. (NASDAQ:ANIX) entered into a letter of intent with VERDI Solutions GmbH to develop personalized and off-the-shelf peptide vaccines for cancer patients. VERDI ...